However, we did not observe a significant degree of compensatory proliferation or proliferative capacity of hepatocytes in Pgrmc1-null livers in terms of Ki67 immunostaining and the transcript levels of HCC proliferation markers (i.e., c-Myc, Cyclin D, and Hgf). This evidence concerns the gene PGRMC1 and hepatocellular carcinoma.